1-20 of 35
Steven P. Balk
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Autocrine Canonical Wnt Signaling Primes Noncanonical Signaling through ROR1 in Metastatic Castration-Resistant Prostate Cancer

Fen Ma, Seiji Arai, Keshan Wang, Carla Calagua, Amanda R. Yuan, Larysa Poluben, Zhongkai Gu, Joshua W. Russo, David J. Einstein, Huihui Ye, Meng Xiao He, Yu Liu, Eliezer Van Allen, Adam G. Sowalsky, Manoj K. Bhasin, Xin Yuan, Steven P. Balk
Journal: Cancer Research
Cancer Res (2022) 82 (8): 1518–1533.
DOI: https://doi.org/10.1158/0008-5472.CAN-21-1807
Published: 15 April 2022
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract 973: The selective polo-like kinase (Plk1) inhibitor onvansertib and the antiandrogen abiraterone synergistically kill cancer cells through disruption of mitosis independently of androgen receptor signaling

Jesse C. Patterson, Peter J. Croucher, Maya Ridinger, David J. Einstein, Andreas Varkaris, Steven P. Balk, Glenn J. Bubley, Mark G. Erlander, Michael B. Yaffe
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 973.
DOI: https://doi.org/10.1158/1538-7445.AM2021-973
Published: 01 July 2021
View article
Journal Articles

ATM Loss Confers Greater Sensitivity to ATR Inhibition Than PARP Inhibition in Prostate Cancer

Shahrzad Rafiei, Kenyon Fitzpatrick, David Liu, Mu-Yan Cai, Haitham A. Elmarakeby, Jihye Park, Cora Ricker, Bose S. Kochupurakkal, Atish D. Choudhury, William C. Hahn, Steven P. Balk, Justin H. Hwang, Eliezer M. Van Allen, Kent W. Mouw
Journal: Cancer Research
Series: Author Choice
Cancer Res (2020) 80 (11): 2094–2100.
DOI: https://doi.org/10.1158/0008-5472.CAN-19-3126
Published: 02 June 2020
View article
PDF
Includes: Supplementary data
Journal Articles

ZBTB7A Mediates the Transcriptional Repression Activity of the Androgen Receptor in Prostate Cancer

Dong Han, Sujun Chen, Wanting Han, Shuai Gao, Jude N. Owiredu, Muqing Li, Steven P. Balk, Housheng Hansen He, Changmeng Cai
Journal: Cancer Research
Cancer Res (2019) 79 (20): 5260–5271.
DOI: https://doi.org/10.1158/0008-5472.CAN-19-0815
Published: 15 October 2019
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract 923: FOXA1 chromatin binding is regulated by LSD1-mediated methylation in prostate cancer cells

Shuai Gao, Sujun Chen, Dong Han, Wanting Han, Jude N. Owiredu, Steven P. Balk, Housheng H. He, Changmeng Cai
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 923.
DOI: https://doi.org/10.1158/1538-7445.AM2019-923
Published: 01 July 2019
View article
Journal Articles

Abstract 395: Aberrant HER2 signaling is a therapeutic target in a subset of castration-resistant prostate cancer

Joshua W. Russo, Xin Gao, David J. Einstein, Glenn J. Bubley, Steven P. Balk
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 395.
DOI: https://doi.org/10.1158/1538-7445.AM2019-395
Published: 01 July 2019
View article
Journal Articles

Downregulation of Dipeptidyl Peptidase 4 Accelerates Progression to Castration-Resistant Prostate Cancer

Joshua W. Russo, Ce Gao, Swati S. Bhasin, Olga S. Voznesensky, Carla Calagua, Seiji Arai, Peter S. Nelson, Bruce Montgomery, Elahe A. Mostaghel, Eva Corey, Mary-Ellen Taplin, Huihui Ye, Manoj Bhasin, Steven P. Balk
Journal: Cancer Research
Cancer Res (2018) 78 (22): 6354–6362.
DOI: https://doi.org/10.1158/0008-5472.CAN-18-0687
Published: 15 November 2018
View article
PDF
Includes: Supplementary data
Journal Articles

BMX-Mediated Regulation of Multiple Tyrosine Kinases Contributes to Castration Resistance in Prostate Cancer

Sen Chen, Changmeng Cai, Adam G. Sowalsky, Huihui Ye, Fen Ma, Xin Yuan, Nicholas I. Simon, Nathanael S. Gray, Steven P. Balk
Journal: Cancer Research
Cancer Res (2018) 78 (18): 5203–5215.
DOI: https://doi.org/10.1158/0008-5472.CAN-17-3615
Published: 14 September 2018
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract A041: LSD1 inhibition disrupts FOXA1-dependent AR cistrome

Shuai Gao, Dong Han, Sujun Chen, Wanting Han, Housheng Hansen He, Steven P. Balk, Changmeng Cai
Journal: Cancer Research
Cancer Res (2018) 78 (16_Supplement): A041.
DOI: https://doi.org/10.1158/1538-7445.PRCA2017-A041
Published: 14 August 2018
View article
Journal Articles

Abstract A024: Prostate cancer neoadjuvant intensive androgen deprivation therapy selects for tumor foci with diverse oncogenic alterations

Adam G. Sowalsky, Huihui Ye, Manoj Bhasin, Eliezer M. Van Allen, Massimo Loda, Rosina T. Lis, Laleh Montaser, Carla Calagua, Fen Ma, Joshua W. Russo, Rachel J. Schaefer, Olga S. Voznesensky, Zhenwei Zhang, Glenn J. Bubley, Robert B. Montgomery, Elahe A. Mostaghel, Peter S. Nelson, Mary-Ellen Taplin, Steven P. Balk
Journal: Cancer Research
Cancer Res (2018) 78 (16_Supplement): A024.
DOI: https://doi.org/10.1158/1538-7445.PRCA2017-A024
Published: 14 August 2018
View article
Journal Articles

Neoadjuvant-Intensive Androgen Deprivation Therapy Selects for Prostate Tumor Foci with Diverse Subclonal Oncogenic Alterations

Adam G. Sowalsky, Huihui Ye, Manoj Bhasin, Eliezer M. Van Allen, Massimo Loda, Rosina T. Lis, Laleh Montaser-Kouhsari, Carla Calagua, Fen Ma, Joshua W. Russo, Rachel J. Schaefer, Olga S. Voznesensky, Zhenwei Zhang, Glenn J. Bubley, Bruce Montgomery, Elahe A. Mostaghel, Peter S. Nelson, Mary-Ellen Taplin, Steven P. Balk
Journal: Cancer Research
Cancer Res (2018) 78 (16): 4716–4730.
DOI: https://doi.org/10.1158/0008-5472.CAN-18-0610
Published: 14 August 2018
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract 5497: LSD1 modulates androgen receptor cistrome in prostate cancer via regulation of FOXA1 chromatin binding

Shuai Gao, Sujun Chen, Dong Han, Wanting Han, Steven P. Balk, Housheng Hansen He, Changmeng Cai
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 5497.
DOI: https://doi.org/10.1158/1538-7445.AM2017-5497
Published: 01 July 2017
View article
Journal Articles

Abstract 4979: Cabozantinib eradicates advanced murine prostate cancer by activating neutrophil-mediated anti-tumor innate immunity

Akash Patnaik, Kenneth D. Swanson, Eva Csizmadia, Marina P. Gehring, Katja Helenius, Athalia R. Pyzer, Lily C. Wang, Jesse Novak, Olivier Elemento, Thomas B. Thornley, John M. Asara, John G. Clohessy, Kathy Kelly, Pier Paolo Pandolfi, Jacalyn M. Rosenblatt, David E. Avigan, Huihui Ye, Sabina Signoretti, Steven P. Balk, Lewis C. Cantley
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 4979.
DOI: https://doi.org/10.1158/1538-7445.AM2016-4979
Published: 15 July 2016
View article
Journal Articles

Abstract A2-11: PLZF, a tumor suppressor genetically lost in metastatic castration resistant prostate cancer, is a mediator of resistance to androgen deprivation therapy

Chen-Lin Hsieh, Ginevra Botta, Shuai Gao, Tiantian Li, Eliezer M. Van Allen, Daniel J. Treacy, Changmeng Cai, Housheng Hansen He, Christopher J. Sweeney, Myles Brown, Steven P. Balk, Peter S. Nelson, Levi A. Garraway, Philip W. Kantoff
Journal: Cancer Research
Cancer Res (2015) 75 (22_Supplement_1): A2-11.
DOI: https://doi.org/10.1158/1538-7445.TRANSCAGEN-A2-11
Published: 15 November 2015
View article
Journal Articles

Abstract 1849: Androgen receptor transcriptionally represses genes mediating DNA synthesis and repair in prostate cancer

Yanfei Gao, Shuai Gao, Housheng He, Xiaming Liu, Sen Chen, Fen Ma, X. Shirley Liu, Myles Brown, Steven P. Balk, Shaoyong Chen, Changmeng Cai
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 1849.
DOI: https://doi.org/10.1158/1538-7445.AM2015-1849
Published: 01 August 2015
View article
Journal Articles

Abstract 3450: Resistance to P450c17 inhibitors in castration-resistant prostate cancer may result from the DHEA-S depot that remains and can be used by AKR1C3 for intratumoral androgen biosynthesis

Daniel Tamae, Elahe Mostaghel, Bruce Montgomery, Peter S. Nelson, Steven P. Balk, Philip W. Kantoff, Mary-Ellen Taplin, Trevor M. Penning
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 3450.
DOI: https://doi.org/10.1158/1538-7445.AM2015-3450
Published: 01 August 2015
View article
Journal Articles

PLZF, a Tumor Suppressor Genetically Lost in Metastatic Castration-Resistant Prostate Cancer, Is a Mediator of Resistance to Androgen Deprivation Therapy

Chen-Lin Hsieh, Ginevra Botta, Shuai Gao, Tiantian Li, Eliezer M. Van Allen, Daniel J. Treacy, Changmeng Cai, Housheng Hansen He, Christopher J. Sweeney, Myles Brown, Steven P. Balk, Peter S. Nelson, Levi A. Garraway, Philip W. Kantoff
Journal: Cancer Research
Cancer Res (2015) 75 (10): 1944–1948.
DOI: https://doi.org/10.1158/0008-5472.CAN-14-3602
Published: 13 May 2015
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract A46: LSD1 globally mediates epigenetic modifications on androgen receptor-dependent enhancers

Changmeng Cai, Housheng Hansen He, Myles Brown, Steven P. Balk
Journal: Cancer Research
Cancer Res (2013) 73 (13_Supplement): A46.
DOI: https://doi.org/10.1158/1538-7445.CEC13-A46
Published: 13 May 2014
View article
Journal Articles

Abstract B12: LSD1 mediates global AR transcription suppression in prostate cancer cells

Changmeng Cai, Housheng He, Sen Chen, X. Shirley Liu, Myles Brown, Steven P. Balk
Journal: Cancer Research
Cancer Res (2012) 72 (4_Supplement): B12.
DOI: https://doi.org/10.1158/1538-7445.PRCA2012-B12
Published: 09 May 2013
View article
Journal Articles

Abstract C3: Receptor tyrosine kinase(s) modulate androgen receptor signaling in castrate-resistant prostate cancer

Ankur Sharma, Steven P. Balk
Journal: Cancer Research
Cancer Res (2012) 72 (4_Supplement): C3.
DOI: https://doi.org/10.1158/1538-7445.PRCA2012-C3
Published: 09 May 2013
View article